Ipsen is a global specialty-driven pharmaceutical company and also has a significant presence in consumer healthcare. Their ambition is to become a leader in the treatment of targeted debilitating diseases.
Ipsen's areas of expertise include oncology, neurosciences, endocrinology (adult and child) and gastroenterology. Their commitment to oncology is demonstrated by a growing portfolio of therapies aimed at improving the lives of patients with neuroendocrine tumors, prostate, bladder and kidney cancer.
Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in 30 countries worldwide. The Group employs more than 4,600 people around the globe.
The Blake Project was selected to lead an advanced brand education program based on the combination of our brand management expertise and our understanding of pharmaceutical and medical markets.